Log in  First Connection?

Kidney TransplantationArchives

Intraoperative Mean Arterial Pressure and Postoperative Delayed Graft Function in Kidney Transplantation: Evaluating Three Commonly Used Thresholds

 Published on 02/10/2024 |  Original article (Full-text)  | Chinnarat Pongpruksa et al. | Clinical Transplantation 2024; 38(9): 15458

Delayed graft function (DGF), commonly defined as the failure of the kidney to function promptly and the need for dialysis within the first 7 days after transplantation, is one of the common early complications after kidney transplantation (KT) [1, 2]. DGF is associated with various long‐term adverse...

Preoperative CD52 Level Predicts Graft Survival following Kidney Transplantation

 Published on 25/09/2024 |  Original article (Full-text)  | Ramouz Ali et al. | BioMed Research International 2022 (2022), Article ID 8949919, 7 pages

Patients with end-stage renal disease (ESRD) are optimally treated with kidney transplantation (KTx) [1] because it is associated with better quality of life and longer life expectancy [2]. Although patient and graft survival have considerably increased following KTx in recent decades, KTx recipients...

Impact of single centre kidney‐exchange transplantation to increase living donor pool in India: A cohort study involving non‐anonymous allocation

 Published on 18/09/2024 |  Original article (Full-text)  | Vivek B. Kute et al. | Nephrology 2024; AOP: 10.1111/nep.14380

The Global Observatory on Donation and Transplantation notes that India is the third largest in the world in terms of total transplant volume, behind the United States and China. Approximately 85% of kidney transplantations in India are from living donors, and only 15% are derived from deceased donors....

Influence of intravenous iron on bacterial infection risk immediately following kidney transplantation

 Published on 11/09/2024 |  Original article (Full-text)  | Spenser E. January et al. | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2024; AOP: 10.1002/phar.4608

Individuals with chronic or end‐stage kidney disease have a high prevalence of anemia due to decreased erythropoietin production, iron loss secondary to chronic hemodialysis, and impaired iron absorption from upregulation of hepcidin. Prevalence of anemia in this population ranges between 17% and...